1. Jager, K. J. et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant 34, 1803–1805 (2019).
2. Luyckx, V. A. et al. Sustainable Development Goals relevant to kidney health: an update on progress. Nat Rev Nephrol 17, 15–32 (2021).
3. Gunasekara, T. D. K. S. C. et al. The Utility of Novel Renal Biomarkers in Assessment of Chronic Kidney Disease of Unknown Etiology (CKDu): A Review. Int J Environ Res Public Health 17, (2020).
4. Babich, R. et al. Kidney developmental effects of metal-herbicide mixtures: Implications for chronic kidney disease of unknown etiology. Environ Int 144, 106019 (2020).
5. Jayasumana, C. et al. Chronic interstitial nephritis in agricultural communities: a worldwide epidemic with social, occupational and environmental determinants. Nephrol Dial Transplant 32, 234–241 (2017).
6. Lunyera, J. et al. CKD of Uncertain Etiology: A Systematic Review. Clin J Am Soc Nephrol 11, 379–385 (2016).
7. Wijewickrama, E. S., Gunawardena, N., Jayasinghe, S. & Herath, C. CKD of Unknown Etiology (CKDu) in Sri Lanka: A Multilevel Clinical Case Definition for Surveillance and Epidemiological Studies. Kidney International Reports 4, 781–785 (2019).
8. Agampodi, S. B., Amarasinghe, G. S., Naotunna, P. G. C. R., Jayasumana, C. S. & Siribaddana, S. H. Early renal damage among children living in the region of highest burden of chronic kidney disease of unknown etiology (CKDu) in Sri Lanka. BMC Nephrol 19, 115 (2018).
9. Leibler, J. H. et al. Biomarkers of kidney injury among children in a high-risk region for chronic kidney disease of uncertain etiology. Pediatr Nephrol 36, 387–396 (2021).
10. Ranasinghe, A. V. et al. The incidence, prevalence and trends of Chronic Kidney Disease and Chronic Kidney Disease of uncertain aetiology (CKDu) in the North Central Province of Sri Lanka: an analysis of 30,566 patients. BMC Nephrology 20, 338 (2019).
11. Orantes-Navarro, C. M. et al. Toward a Comprehensive Hypothesis of Chronic Interstitial Nephritis in Agricultural Communities. Adv Chronic Kidney Dis 24, 101–106 (2017).
12. Athuraliya, N. T. C. et al. Uncertain etiologies of proteinuric-chronic kidney disease in rural Sri Lanka. Kidney International 80, 1212–1221 (2011).
13. Lopez-Giacoman, S. & Madero, M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol 4, 57–73 (2015).
14. List of Qualified Biomarkers | FDA. https://www.fda.gov/drugs/biomarker-qualification-program/list-qualified-biomarkers.
15. Ichimura, T. et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273, 4135–4142 (1998).
16. Ismail, O. Z., Zhang, X., Bonventre, J. V. & Gunaratnam, L. G protein α12 (Gα12) is a negative regulator of kidney injury molecule-1-mediated efferocytosis. Am J Physiol Renal Physiol 310, F607–F620 (2016).
17. Yin, C. & Wang, N. Kidney injury molecule-1 in kidney disease. Ren Fail 38, 1567–1573 (2016).
18. Bonventre, J. V. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 24, 3265–3268 (2009).
19. Bonventre, J. V. Kidney injury molecule-1: a translational journey. Trans Am Clin Climatol Assoc 125, 293–299; discussion 299 (2014).
20. Moresco, R. N. et al. Urinary kidney injury molecule-1 in renal disease. Clin Chim Acta 487, 15–21 (2018).
21. Zhang, Z., Humphreys, B. D. & Bonventre, J. V. Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. J Am Soc Nephrol 18, 2704–2714 (2007).
22. Flower, D. R., North, A. C. & Attwood, T. K. Structure and sequence relationships in the lipocalins and related proteins. Protein Sci 2, 753–761 (1993).
23. Xu, S. Y. et al. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest 54, 365–376 (1994).
24. Cowland, J. B. & Borregaard, N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45, 17–23 (1997).
25. Devarajan, P. Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Ther 5, 463–470 (2007).
26. Schmidt-Ott, K. M. et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18, 407–413 (2007).
27. Shemin, D. & Dworkin, L. D. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury. Crit Care Clin 27, 379–389 (2011).
28. De Silva, P. M. C. S. et al. Urinary Biomarkers KIM-1 and NGAL for Detection of Chronic Kidney Disease of Uncertain Etiology (CKDu) among Agricultural Communities in Sri Lanka. PLoS Negl Trop Dis 10, e0004979 (2016).
29. Kafle, K., Balasubramanya, S. & Horbulyk, T. Prevalence of chronic kidney disease in Sri Lanka: A profile of affected districts reliant on groundwater. Sci Total Environ 694, 133767 (2019).
30. Arya, R., Antonisamy, B. & Kumar, S. Sample size estimation in prevalence studies. Indian J Pediatr 79, 1482–1488 (2012).
31. Le, X. Q. et al. Urinary biomarkers of early renal injury in antiretroviral-naïve HIV-positive persons in Shanghai, China: comparison with the general population. HIV Med 22, 750–758 (2021).
32. McWilliam, S. J. et al. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomark Med 8, 1189–1197 (2014).
33. Bennett, M. R., Nehus, E., Haffner, C., Ma, Q. & Devarajan, P. Pediatric reference ranges for acute kidney injury biomarkers. Pediatr Nephrol 30, 677–685 (2015).
34. Kamianowska, M., Szczepański, M., Kulikowska, E. E., Bebko, B. & Wasilewska, A. Do serum and urinary concentrations of kidney injury molecule-1 in healthy newborns depend on birth weight, gestational age or gender? J Perinatol 37, 73–76 (2017).
35. De Silva, P. M. C. S. et al. Urinary Biomarkers of Renal Injury KIM-1 and NGAL: Reference Intervals for Healthy Pediatric Population in Sri Lanka. Children (Basel) 8, 684 (2021).
36. Senevirathna, L. et al. Risk factors associated with disease progression and mortality in chronic kidney disease of uncertain etiology: a cohort study in Medawachchiya, Sri Lanka. Environ Health Prev Med 17, 191–198 (2012).
37. Ramírez-Rubio, O. et al. Urine biomarkers of kidney injury among adolescents in Nicaragua, a region affected by an epidemic of chronic kidney disease of unknown aetiology. Nephrol Dial Transplant 31, 424–432 (2016).
38. Glaser, J. et al. Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy. Clin J Am Soc Nephrol 11, 1472–1483 (2016).
39. Roncal-Jimenez, C., Lanaspa, M. A., Jensen, T., Sanchez-Lozada, L. G. & Johnson, R. J. Mechanisms by Which Dehydration May Lead to Chronic Kidney Disease. Ann Nutr Metab 66 Suppl 3, 10–13 (2015).
40. Roncal-Jimenez, C. A., García-Trabanino, R., Wesseling, C. & Johnson, R. J. Mesoamerican Nephropathy or Global Warming Nephropathy? Blood Purif 41, 135–138 (2016).
41. Herath, C. et al. Kidney Diseases in Agricultural Communities: A Case Against Heat-Stress Nephropathy. Kidney Int Rep 3, 271–280 (2018).
42. Li, P. K.-T. et al. A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004. Kidney Int Suppl S2-7 (2005) doi:10.1111/j.1523-1755.2005.09401.x.
43. Narva, A. Screening is part of kidney disease education. Clin J Am Soc Nephrol 2, 1352–1354 (2007).
44. Hogg, R. J. Screening for CKD in children: a global controversy. Clin J Am Soc Nephrol 4, 509–515 (2009).
45. Sato, Y., Takahashi, M. & Yanagita, M. Pathophysiology of AKI to CKD progression. Semin Nephrol 40, 206–215 (2020).